Skip to content
Sign in
European CDMOs compared · 2026 census

CDMOs in Greece: 8 compared (2026)

8 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Greece. The largest, with revenue over €1bn, are Famar and Pharmathen. 3 sit between €250m and €1bn and 3 are smaller or niche.

By ownership: 5 family-owned, 2 private equity and 1 listed. The most common capabilities are sterile fill-finish (8), oral solid dose (4), peptide (1) and small-molecule API (1). 6 of the 8 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.

Open these 8 in the interactive mapAll 255 European CDMOs

8 companies

CDMOs in Greece

CompanyHQOwnershipSizeRevenue (as reported)ModalitiesData
FamarOne of Europe's largest pure-play pharma/consumer-health CDMOs; 70+ yr legacy. Sterile injectables, eye drops, syrups, solids. 80 markets.AlimosPrivate equityMidEuropaTier 1not disclosedOral solid dose, Sterile fill-finishhigh
PharmathenVertically integrated developer of complex drug-delivery tech offering CDMO/co-development: long-acting injectables, SR oral solids, ophthalmics.PalliniPrivate equityPartners GroupTier 1not disclosedOral solid dose, Sterile fill-finish, Peptidehigh
DEMOPrimarily own-product (largest injectables supplier to Greek hospitals) but lists contract manufacturing. Own-API from 2019.KrioneriFamily-ownedTier 2not disclosedSterile fill-finish, Small-molecule APImedium
RafarmEnd-to-end CDMO/CMO (50 yrs); third-party contract manufacturing of sterile ophthalmics and complex injectables (robotic sterile lines).PaianiaFamily-ownedTier 2not disclosedSterile fill-finishhigh
Vianex90+ yr firm; long-standing contract manufacturer (exclusive local/export production for MSD since 1983). Cephalosporins + solids/injectables.Nea ErythraiaFamily-ownedGiannakopoulos familyTier 2not disclosedOral solid dose, Sterile fill-finishhigh
Anfarm HellasEU-GMP manufacturer offering 3rd-party manufacturing / CDMO / tech transfer. Specializes in lyophilised products, liquid injectables, beta-lactams.KifissiaFamily-ownedTier 3not disclosedSterile fill-finishhigh
Iasis PharmaProvides CDMO/CMO services alongside own products (since 1985). Broad dosage forms; exports to 36 countries.KoropiFamily-ownedTier 3not disclosedOral solid dose, Sterile fill-finishhigh
LavipharmSpecialist developer/manufacturer of transdermal drug delivery systems (TDDS) — one of few integrated TDDS lines in Europe; CDMO services.PeaniaListedTier 3not disclosedSterile fill-finishmedium

Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).

Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.

Browse the census

Other European CDMO lists